JP5285279B2 - 経皮吸収型製剤 - Google Patents

経皮吸収型製剤 Download PDF

Info

Publication number
JP5285279B2
JP5285279B2 JP2007552906A JP2007552906A JP5285279B2 JP 5285279 B2 JP5285279 B2 JP 5285279B2 JP 2007552906 A JP2007552906 A JP 2007552906A JP 2007552906 A JP2007552906 A JP 2007552906A JP 5285279 B2 JP5285279 B2 JP 5285279B2
Authority
JP
Japan
Prior art keywords
patch
drug
adhesive layer
sensitive adhesive
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2007552906A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2007077741A1 (ja
Inventor
崇 安河内
継良 遠藤
哲郎 立石
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Priority to JP2007552906A priority Critical patent/JP5285279B2/ja
Publication of JPWO2007077741A1 publication Critical patent/JPWO2007077741A1/ja
Application granted granted Critical
Publication of JP5285279B2 publication Critical patent/JP5285279B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007552906A 2005-12-28 2006-12-20 経皮吸収型製剤 Active JP5285279B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007552906A JP5285279B2 (ja) 2005-12-28 2006-12-20 経皮吸収型製剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005378796 2005-12-28
JP2005378796 2005-12-28
JP2007552906A JP5285279B2 (ja) 2005-12-28 2006-12-20 経皮吸収型製剤
PCT/JP2006/325399 WO2007077741A1 (fr) 2005-12-28 2006-12-20 Preparation absorbable par voie transdermique

Publications (2)

Publication Number Publication Date
JPWO2007077741A1 JPWO2007077741A1 (ja) 2009-06-11
JP5285279B2 true JP5285279B2 (ja) 2013-09-11

Family

ID=38228097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007552906A Active JP5285279B2 (ja) 2005-12-28 2006-12-20 経皮吸収型製剤

Country Status (2)

Country Link
JP (1) JP5285279B2 (fr)
WO (1) WO2007077741A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5209433B2 (ja) * 2007-10-19 2013-06-12 日東電工株式会社 貼付製剤
KR101590209B1 (ko) * 2008-05-30 2016-02-01 밀란 인크. 안정화 경피 약물 전달 시스템
US20130338122A1 (en) * 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
KR102013476B1 (ko) * 2012-07-26 2019-08-22 히사미쓰 세이야꾸 가부시키가이샤 첩부제 및 그 제조 방법
JP6370802B2 (ja) * 2012-12-28 2018-08-08 テイコク ファーマ ユーエスエー インコーポレーテッド 持続性ブプレノルフィン経皮送達組成物およびそれの使用方法
JP2014148492A (ja) * 2013-02-04 2014-08-21 Asanuma Corporation シャンプー組成物
MX2015013727A (es) * 2013-04-04 2016-02-29 Hyundai Pharm Co Ltd Composicion para preparacion de uso externo con permeabilidad transdermica mejorada.
MA41266A (fr) * 2014-12-22 2017-10-31 Hisamitsu Pharmaceutical Co Cataplasme

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051575A1 (fr) * 1999-03-01 2000-09-08 Amarin Technologies S.A. Dispositif transdermique comprenant des anti-inflammatoires non steroidiens integres dans une matrice polymere adhesive acrylique
US6267984B1 (en) * 1997-12-22 2001-07-31 Alza Corporation Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
JP2002542277A (ja) * 1999-04-22 2002-12-10 エルティエス ローマン テラピー−ズュステーメ アーゲー 中和されたアクリル性粘着パッチを備えた経皮治療システム
JP2003533471A (ja) * 2000-05-16 2003-11-11 サムヤン コーポレイション 経皮薬剤送出用のヒドロゲル組成物
JP2004512356A (ja) * 2000-11-06 2004-04-22 サムヤン　コーポレイション 改善された水分吸収能および接着性を有する経皮投与剤
WO2005002482A1 (fr) * 2002-05-23 2005-01-13 Agile Therapeutics, Inc. Systeme de delivrance d'hormones transdermique : compositions et procedes

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267984B1 (en) * 1997-12-22 2001-07-31 Alza Corporation Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
WO2000051575A1 (fr) * 1999-03-01 2000-09-08 Amarin Technologies S.A. Dispositif transdermique comprenant des anti-inflammatoires non steroidiens integres dans une matrice polymere adhesive acrylique
JP2002542277A (ja) * 1999-04-22 2002-12-10 エルティエス ローマン テラピー−ズュステーメ アーゲー 中和されたアクリル性粘着パッチを備えた経皮治療システム
JP2003533471A (ja) * 2000-05-16 2003-11-11 サムヤン コーポレイション 経皮薬剤送出用のヒドロゲル組成物
JP2004512356A (ja) * 2000-11-06 2004-04-22 サムヤン　コーポレイション 改善された水分吸収能および接着性を有する経皮投与剤
WO2005002482A1 (fr) * 2002-05-23 2005-01-13 Agile Therapeutics, Inc. Systeme de delivrance d'hormones transdermique : compositions et procedes

Also Published As

Publication number Publication date
WO2007077741A1 (fr) 2007-07-12
JPWO2007077741A1 (ja) 2009-06-11

Similar Documents

Publication Publication Date Title
KR101734602B1 (ko) 도네페질 함유 경피 흡수형 제제
JP4703075B2 (ja) 外用貼付剤
JP5285279B2 (ja) 経皮吸収型製剤
JP4422430B2 (ja) エストロゲン及び／又はプロゲストゲン含有外用貼付剤
JP5403948B2 (ja) メマンチン含有経皮吸収製剤
JP4694967B2 (ja) 貼付剤
JPH1045570A (ja) フェンタニル含有経皮投与テープ製剤
TW201717921A (zh) 貼附劑
JP4678532B2 (ja) 非ステロイド消炎鎮痛薬を含有する非水系経皮吸収製剤
JP4986411B2 (ja) 貼付剤
US20080188509A1 (en) Transdermal Preparations and Method for Relieving Side Effects in Pergolide Therapy
EP2143445B1 (fr) Timbre médicamenteux
JP5091472B2 (ja) 粘着剤及び貼付剤
JP4283507B2 (ja) 経皮投与用貼付剤
EP1611882B1 (fr) Patch adhésif
JP5564241B2 (ja) フェルビナク含有経皮吸収製剤
WO2016208729A1 (fr) Patch d'absorption percutanée contenant de la nalfurafine
JP4404251B2 (ja) 経皮吸収型製剤
TWI519323B (zh) 含有聯苯乙酸之外用貼附劑
WO2019167693A1 (fr) Timbre contenant du méthylphénidate
JPWO2011074567A1 (ja) 塩基性消炎鎮痛剤含有経皮吸収製剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091028

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120529

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130208

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130528

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130531

R150 Certificate of patent or registration of utility model

Ref document number: 5285279

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250